MY198042A - Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process - Google Patents

Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process

Info

Publication number
MY198042A
MY198042A MYPI2014000195A MYPI2014000195A MY198042A MY 198042 A MY198042 A MY 198042A MY PI2014000195 A MYPI2014000195 A MY PI2014000195A MY PI2014000195 A MYPI2014000195 A MY PI2014000195A MY 198042 A MY198042 A MY 198042A
Authority
MY
Malaysia
Prior art keywords
prophylaxis
treatment
compounds
pharmaceutical compositions
vii
Prior art date
Application number
MYPI2014000195A
Inventor
Mikhail Gennadievich Shurygin
Irina Aleksandrovna Shurygina
Original Assignee
Pharmasyntez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmasyntez filed Critical Pharmasyntez
Priority claimed from PCT/IB2012/052483 external-priority patent/WO2012156938A1/en
Publication of MY198042A publication Critical patent/MY198042A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to the field of pharmacy, clinical and experimental medicine and veterinary medicine, and in particular to novel inhibitory compounds of a p38 MAP kinase having a structure of type (I)-(VII) which can be used for the treatment or prophylaxis of adhesion. The invention discloses pharmaceutical compositions containing an effective amount of the substance SB203580 or one or more of the conjugated compounds of type (I)-(VII) or a combination thereof, and a pharmaceutically acceptable carrier, a diluent or an excipient. Also disclosed is the use of the substance SB203580 as an agent having anti- adhesion activity. Also disclosed is a method for the prophylaxis and/or treatment of a disease or a condition in which there is a possibility of the formation and/or growth of adhesions, which makes it possible to dispense with the additional administration of a preparation in the post-operative period.
MYPI2014000195A 2011-05-17 2012-05-17 Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process MY198042A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2011119848/15A RU2011119848A (en) 2011-05-17 2011-05-17 METHOD FOR PREVENTION OF SPIKE EDUCATION
PCT/IB2012/052483 WO2012156938A1 (en) 2011-05-17 2012-05-17 Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process

Publications (1)

Publication Number Publication Date
MY198042A true MY198042A (en) 2023-07-27

Family

ID=49254499

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2014000195A MY198042A (en) 2011-05-17 2012-05-17 Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process

Country Status (4)

Country Link
CU (1) CU20130154A7 (en)
MY (1) MY198042A (en)
RU (1) RU2011119848A (en)
UA (1) UA113733C2 (en)

Also Published As

Publication number Publication date
RU2011119848A (en) 2012-11-27
CU20130154A7 (en) 2014-05-27
UA113733C2 (en) 2017-03-10

Similar Documents

Publication Publication Date Title
WO2013003629A3 (en) Methods and compositions for inhibition of bone resorption
NI201100194A (en) DERIVATIVES OF HAVE [2, 3 - B] PYRIDINE AS INHIBITORS OF VIRAL REPLICATION
WO2011127333A3 (en) Compounds for treating disease, for administering, and for pharmaceutical compositions
MX368504B (en) Amide derivatives and pharmaceutically acceptable salts thereof, preparation method therefor and medicinal application thereof.
TN2015000368A1 (en) Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
MX2008013212A (en) 4-anilinoquinoline-3-carboxamides as csf-1r kinase inhibitors.
BR112015003188A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, COMPOUND USE, AND METHOD FOR TREATMENT OF A RORGAMMAT-MEDIATED DISEASE OR CONDITION IN A PATIENT
MX2011012122A (en) Thiophene derivatives.
MX2015003653A (en) Benzoimidazole-carboxylic acid amide derivatives as apj receptor modulators.
WO2013147649A3 (en) Inhibitors of the pi3k/akt/ikk/nf-kb signalling pathway, pharmaceutically acceptable salts thereof and compositions containing said inhibitors for the prophylaxis and treatment of viral diseases
BR112014026493A2 (en) imidazotiadiazole derivatives as protease activated receptor 4 (par4) inhibitors to treat platelet aggregation
MX2013007558A (en) 1,4 oxazines as bace1 and/or bace2 inhibitors.
MX2013010795A (en) 1,3 oxazines as bace1 and/or bace2 inhibitors.
BR112013011634A2 (en) amino alcohol substituted 2,3-dihydroimidazole [1,2-c] quinazoline derivatives useful for treating hyperproliferative disorders and diseases associated with angiogenesis 2,3-dihydroimidazole [1,2-c] derivatives
UA104489C2 (en) Compounds for the treatment of dyslipidemia and related diseases
MX2009004908A (en) Chemical compounds.
MX2013007957A (en) 1,4 oxazines as bace1 and/or bace2 inhibitors.
WO2012064897A3 (en) Bicyclic and tricyclic inhibitors of sumoylation enzymes and methods for their use
WO2009125434A3 (en) Oxime derivatives, process for their preparation, pharmaceutical composition containing the same and medicinal use thereof
UA104988C2 (en) Novel pyrone-indole derivatives and process for their preparation
EA201390984A1 (en) HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA
MX341577B (en) Morpholino substituted bicyclic pyrimidine urea or carbamate derivatives as mtor inhibitors.
BR112014028813A2 (en) 5-amino [1,4] thiazines as bace1 inhibitors
CY1122190T1 (en) COMPOUNDS FOR THE PREVENTION AND TREATMENT OF THE ADHESION PROCESS
WO2018005794A3 (en) Novel non-systemic tgr5 agonists